Passerini R, Ghezzi Tl, Sandri Mt, Radice D, Biffi R
Laboratory Medicine Unit, European Institute of Oncology, Milan, Italy.
Ecancermedicalscience. 2011;5:191. doi: 10.3332/ecancer.2011.191. Epub 2011 Feb 17.
Bloodstream infections (BSIs) are one of the major life-threatening infectious conditions in cancer patients and are responsible for prolonged hospital stays, high healthcare costs and significant mortality. Several clinical trials have reported an improved survival in patients treated with appropriate empirical broad-spectrum antibiotic therapy. Early detection of pathogens and determination of their susceptibility are essential for the optimization of treatment. Variability between hospitals is substantial and requires the individual analysis of local trends. The aim of this study is to assess the local epidemiology of BSI in a single cancer centre over a 10-year period.
Retrospective microbiological surveillance of all febrile/infective episodes occurring in oncological and surgical patients in a high-volume cancer centre between January 1999 and December 2008 were considered. Patients' data were collected, processed and analyzed using the epidemiological resource of the Virtuoso Plus software (Metafora Informatica Srl, Milano, Italy). Spearman's rank correlation coefficient, including the two-tailed test of significance, was used to investigate trends of incidence and rate of antibiotic resistance over the 10-year period.
A total of 13,058 blood cultures (BCs) were performed in 2,976 patients. BCs were positive in 2,447 tests, representing 740 infective/febrile episodes: 358 (48%) in medical oncology and 382 (52%) in surgical wards. Gram-positives were responsible for the majority of episodes in oncological and surgical divisions (about 63% and 55%, respectively). Gram-positives were also the most common organism in non-catheter-related BSIs (CRBSIs) both in medical oncology (75%) and in surgical divisions (50%). Enterococci showed an increased resistance to levofloxacin, from 5.6% to 25.7% (p = 0.02) and to erythromycin, from 41.7% to 61.4%, (p = 0.05). Similarly, coagulase negative staphylococci (CoNS) developed resistance to levofloxacin and ciprofloxacin, passing from 33.9% to 67.4% (p = 0.01) and from 5.6% to 25.7% (p = 0.01), respectively.
Gram-positives are the main pathogens of BSIs; there is no difference in aetiology of CRBSIs between surgical and oncological patients. The lower incidence of gram-positive non-CRBSIs in surgical patients was probably due to gram-negative infections secondary to surgical complications.
血流感染(BSIs)是癌症患者面临的主要危及生命的感染性疾病之一,会导致住院时间延长、医疗费用高昂以及显著的死亡率。多项临床试验报告称,接受适当经验性广谱抗生素治疗的患者生存率有所提高。病原体的早期检测及其药敏测定对于优化治疗至关重要。不同医院之间存在很大差异,需要对当地趋势进行个体分析。本研究的目的是评估一个单一癌症中心10年间血流感染的当地流行病学情况。
对1999年1月至2008年12月期间一家大型癌症中心肿瘤内科和外科患者发生的所有发热/感染性发作进行回顾性微生物监测。使用Virtuoso Plus软件(意大利米兰Metafora Informatica Srl公司)的流行病学资源收集、处理和分析患者数据。采用Spearman等级相关系数,包括双侧显著性检验,来研究10年间抗生素耐药性的发病率和发生率趋势。
共对2976例患者进行了13058次血培养(BCs)。2447次检测血培养呈阳性,代表740次感染/发热发作:肿瘤内科358次(48%),外科病房382次(52%)。革兰氏阳性菌是肿瘤内科和外科感染发作的主要原因(分别约为63%和55%)。革兰氏阳性菌也是肿瘤内科(75%)和外科(50%)非导管相关血流感染(CRBSIs)中最常见的病原体。肠球菌对左氧氟沙星的耐药性从5.6%增加到25.7%(p = 0.02),对红霉素的耐药性从41.7%增加到61.4%(p = 0.05)。同样,凝固酶阴性葡萄球菌(CoNS)对左氧氟沙星和环丙沙星的耐药性分别从33.9%增加到67.4%(p = 0.01)和从5.6%增加到25.7%(p = 0.01)。
革兰氏阳性菌是血流感染的主要病原体;外科和肿瘤内科患者的导管相关血流感染病因没有差异。外科患者革兰氏阳性非导管相关血流感染发病率较低可能是由于手术并发症继发的革兰氏阴性感染。